Loquat {Eriobotrya japonica (Lindl.)}, a kind of Chinese herb, has many efficacies such as anti-inflammatory, antimicrobial and curing chronic bronchitis. However, reports on the pharmacological action of wild loquat extract are limited. In this work, the A549 cell line was selected to study the inhibitory effect of ursolic acid and oleanolic acid (UA, OA) from the leaves of E. fragrans. Results showed that UA/OA inhibited A549 cell viability and induced apoptosis in a dose and time dependent manner. The cell fraction in the G0/G1 phase dramatically increased under treatment with UA/OA. Data showed that UA activated the expression of PARP. UA and OA down-regulated MMP-2 and Bcl-2; on the contrary, they up-regulated Bid. This work demonstrated that UA/OA extracted from wild loquat leaves can significantly inhibit the viability of A549 cells.
The cell cycle is arrested in G0/G1 phase in the UA/OA treated A549 cells: Cell cycle distribution was determined with A549 cells treated with different concentrations for 24 h. Figure 3 shows that with increased concentrations (25, 50 µM), cell cycle content slightly increased arrest in G0/G1 phase (UA, 8.4%, 9.6%; OA, 7.2%, 7.7%, respectively), and decreased the S phase number, especially at 50 µM (P<0.01, P<0.05, respectively). This proved that the compounds can induce the arrest of the cell cycle in the G0/G1 phase, although not obviously.
UA/OA regulates the expression of apoptosis related proteins in A549 cells:
We studied the total proteins of A549 cells by Western blot assay (Figure 4 ). Figures 4a, b show that UA/OA concentration-dependently suppressed MMP-2 and Bcl-2 expression, while increasing Bid expression. UA at 75 µM concentration also significantly displayed PARP cleavage activation, but this was not obviously so with OA ( Figure 4c ). The expression of MMP-2, Bcl-2 and Bid in both compounds (75 µM) was quite different from that of the control (P<0.001, P<0.05, respectively).
Studies showed that UA and OA are relatively nontoxic to normal cells [3] . They can inhibit the growth of HCT15 human colon carcinoma cells [12a] , induce apoptosis in HepG2, Hep3B, Huh7 and HA22T liver cancer cell lines [12b], and lower migration and invasion of human breast cancer cells through Akt/mTOR and NF-κB signaling [13] , suggesting that they might be good candidate drugs for cancer targeting therapy. In addition, they are considered to induce apoptosis in B16F-10 melanoma cells, HL-60 leukemia cells, MCF-7 breast cancer cells and DU145 prostate cancer cells [14-16a] .
In our work, UA/OA, which was extracted from Eriobotrya fragrans Champ, can significantly suppress cell viability in a dose and time dependent manner, which is similar to the data of Huang et al. [16b] . This demonstrated that UA treatments decreased the viability of A549, H3255 and Calu-6 cell lines. Cell cycle redistribution usually occurs in UA/OA-induced apoptosis. Some studies reported that UA/OA-induced tumor cell arrest in the G0/G1 phase [17,18a] . Our data indicated that UA/OA treatments can induce A549 cell arrest in the G0/G1 phase, which is in agreement with the work of Hsu et al. [18b] .
The induction of apoptosis function of UA/OA was associated with inhibited expression of MMP-2 and Bcl-2, and increased expression of Bid. Bid is a BH3-only BCL-2 family member with multiple functions [18c, 19] . In most cases it functions in a truncated form. Data showed that the increased Bid expression resulting from treatment may be one of the factors affecting A549 cell apoptosis. Decrease in the expression of pro-apoptotic Bcl-2 proteins or overexpression of anti-apoptotic Bcl-2 protein is associated with enhanced oncogenic potential and poor response rate to chemotherapy [20] . Hsu et al. showed that UA inhibits the expression of anti-apoptotic factor (Bcl-2) resulting in apoptosis [21a] . DecreasedBcl-2 protein expression was observed in the UA/OA-treated A549 cells. In this study, PARP showed cleavage activation in UA groups, but not obviously in the OA group. We suggest that cleavage of PARP also results in slowing of DNA repair and enhancement of the apoptotic process. It has been reported that UA but not OA showed a remarkable anti-invasive activity against invasive human breast MDAMB231 cells. Since the compounds are regioisomers, the difference in their potency may be attributed to the structural arrangements of the substituents [21b]. . Our results indicated that UA and OA have the ability to suppress MMP-2, which is also discussed in the work of Huang et al. [16b] , and also that UA/ OA attenuated cancer cells invasion and migration. In conclusion, this study demonstrates that UA/OA of Eriobotrya fragrans could significantly inhibit the proliferation of A549 cells and induce apoptosis. This suggests that wild loquat is a potential therapeutic herb.
Experimental
Reagents and antibodies: UA/OA used for cell experiments were extracted from the leaves of Eriobotrya fragrans [23d]. UA/OA was dissolved in ethyl alcohol to prepare a 0.01 M stock solution. All the antibodies were provided by Santa Cruz Biotechnology (Santa Cruz, CA, USA). Cyclophosphamide (CY), UA, OA and horseradish peroxidase-conjugated goat anti-mouse secondary antibodies were obtained from Santa Cruz Biotechnology (Santa Cruz, CA, USA).
Cell culture: The A549 human lung carcinoma cell line was obtained from the Medical College of Xiamen University, Xiamen, China, and maintained in Dulbecco's Modified Eagle Medium (DMEM) supplemented with 10% fetal bovine serum (FBS) and 1% penicillin/streptomycin, at 37°C in a water-saturated atmosphere of 5% CO 2 . A549 cells at the exponential growth stage were employed in all of the experiments.
MTT assay: Cells were seeded into 96-well plates at a concentration of 10 4 cells/well in DMEM medium (10% FBS). After 24 h incubation, the medium was replaced with 0.2 mL solution containing various concentrations (0, 25, 50, 75, 100 µM) of UA/OA, then they were incubated for 24 h. The control was treated with 0.1% dimethyl sulfoxide (DMSO) only. After 24 h of incubation, the medium was replaced with methyl thiazolyl tetrazolium (MTT) (final concentration 0.5 mg/mL) in serum-free medium, and followed by another 3 h of incubation. In the same way, cells were treated with UA/OA (50 µM) for different times (0, 12, 24, 36 and 48 h). The MTT formazan product was dissolved in DMSO, and the optical density was measured at 570 nm by a FLUOstar galaxy spectrophotometer. The percentage viability of the treated cells was calculated as follows: cell viability rate (%) = A 570 (test)/A 570 (control) × 100%.
Cell morphological analysis:
Cells were treated with 50 µM UA/OA for 6 h. The control was treated with 0.1% (v/v) DMSO. Then they were incubated with 10 µg/mL Hoechst 33342 (Sigma) for 10 min. After rinsing 3 times with sterile water, the cells were examined for morphological changes using a fluorescence microscope (Leica DMIRB; Germany) with 100× magnification.
Flow cytometry analysis:
Cells were treated with different concentrations of UA/OA, then trypsinized and harvested at different times. After centrifugation, they were washed with PBS, resuspended and stained with Annexin V and propidium iodide (PI), as described in the manufacturer's instructions (Pharmingen, San Diego, CA, USA). The samples were analyzed by flow cytometry (FACScan; Becton Dickinson, Franklin Lakes, NJ, USA).
Cell cycle analysis:
Cell cycle was measured by PI labelling of cellular nuclear DNA. Cells were left overnight to attach to the plate, and then treated with UA/OA. Cell cycle was analyzed using a Becton Dickinson FACScan. The ratios of cells in the G0/G1, S and M phases were calculated from their DNA content. 
